Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Active, not recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

January 2, 2019

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions

Post Intensive Care Syndrome

Trial Locations (5)

Johns Hopkins Hospital, Baltimore

Vanderbilt University, Nashville

Intermountain Medical Center, Murray

George Wahlen Salt Lake City Veterans Administration Hospital, Salt Lake City

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

United States Department of Defense

FED

lead

Vanderbilt University Medical Center

OTHER

NCT03738774 - Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID) | Biotech Hunter | Biotech Hunter